Covino Gregory F Insider Trades

Insider Trading History

Track insider trading activity for Covino Gregory F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Renovacor
Renovacor RCOR
Director
Holding Value $0 0 shares
Last Trade
Dec 01, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$38.4k 12,000 shares
$3.20
$3.20
Renovacor
Renovacor RCOR
Director
Holding Value $38.4k 12,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.3k 12,000 shares
$1.94
$3.20
Renovacor
Renovacor RCOR
Director
Holding Value $38.4k 12,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.3k 12,000 shares
$1.94
$3.20
Chardan Healthcare Acquisition 2
Chardan Healthcare Acquisition 2 CHAQ
Holding Value $202k 24,000 shares
Last Trade
Sep 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 24,000 shares
$7.73
$8.41
Renovacor
Renovacor RCOR
Director
Holding Value $76.8k 24,000 shares
Last Trade
Sep 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 24,000 shares
$7.73
$3.20
Renovacor
Renovacor RCOR
Director
Holding Value $76.8k 24,000 shares
Last Trade
Sep 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 24,000 shares
$7.73
$3.20
Novavax
Novavax NVAX
Evp, Chief Financial Officer
Holding Value $83.6k 8,200 shares
Last Trade
Nov 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$743k 8,200 shares
$90.65
$10.20
Novavax
Novavax NVAX
Evp, Chief Financial Officer
Holding Value $74.5k 7,300 shares
Last Trade
Nov 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662k 7,300 shares
$90.65
$10.20
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $104k 531 shares
Last Trade
Mar 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 531 shares
$282.35
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Feb 23, 2018 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$34k 116 shares
$292.78
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $22.7k 116 shares
Last Trade
Feb 23, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.9k 92 shares
$292.78
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $930k 4,744 shares
Last Trade
Feb 23, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.2k 28 shares
$292.78
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $935k 4,772 shares
Last Trade
Feb 23, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.9k 92 shares
$292.78
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $78.8k 402 shares
Last Trade
Feb 22, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$55.3k 194 shares
$284.81
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $59.2k 302 shares
Last Trade
Feb 22, 2018 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$28.5k 100 shares
$284.81
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $917k 4,680 shares
Last Trade
Feb 22, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.5k 58 shares
$284.81
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $928k 4,738 shares
Last Trade
Feb 22, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$55.3k 194 shares
$284.81
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $101k 514 shares
Last Trade
Feb 15, 2018 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$28.4k 95 shares
$299.38
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $890k 4,544 shares
Last Trade
Feb 15, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 56 shares
$299.38
$195.96
Biogen
Biogen BIIB
Vp, Chief Accounting Officer
Holding Value $119k 609 shares
Last Trade
Feb 15, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.2k 161 shares
$299.38
$195.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up